arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

iRhythm Holdings, Inc.

IRTC
$127.99 ▼ -0.21 (-0.16%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
13 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Bearish
auto_awesome

Analytical Summary

iRhythm Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.1B
Dividend Yield
Revenue Growth 26.2%
Op. Margin -7.7%
ROIC -38.4%
FCF / Share $1.08
Trailing P/E
Price / Book 27.1x
FCF Yield 0.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$747.14M
↑ +26.2%
Net Income Profit after all expenses
$-44.55M
↑ +60.7%
Operating Margin Operating profit as % of sales
-7.7%
↑ +60.6% 17th
FCF / Share Free cash flow per share
$1.08
↑ +210.1%
Long-Term Debt Long-term obligations
$34.95M
— 0.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
27
Returns
23
Financial Health
35
Cash Quality
11

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 45 quarters